Reuters logo
BRIEF-Adaptimmune Therapeutics reports Q4 loss per share $0.04
2017年3月13日 / 下午1点54分 / 7 个月内

BRIEF-Adaptimmune Therapeutics reports Q4 loss per share $0.04

March 13 (Reuters) - Adaptimmune Therapeutics Plc

* Adaptimmune reports fourth quarter and full year 2016 financial results

* Q4 revenue $8.5 million versus $4.0 million

* Q4 revenue view $3.8 million -- Thomson Reuters I/B/E/S

* Adaptimmune Therapeutics Plc - revenue for three months ended December 31, 2016 was $8.5 million compared to $4.0 million in same quarter of prior year

* Adaptimmune Therapeutics Plc - as of december 31, 2016, adaptimmune had a total liquidity position of $181.5 million

* Adaptimmune Therapeutics Plc qtrly loss per share $0.04

* Adaptimmune Therapeutics Plc - company believes that this balance will fund operations through mid-year 2018 Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below